Abstract:Given that TLRs and sphingosine-1-phosphate (S1P) are key players in inflammation, we explored the potential interplay between TLRs and S1P in the adhesion/inflammatory pathways in primary human endothelial cells. As determined by Western blot and flow cytometry, cells treated with LPS (a TLR4 ligand) and S1P showed significantly enhanced expression of adhesion molecules such as ICAM-1 and E-selectin compared with the effect of either ligand alone. Cell-type differences on E-selectin upregulation were observed. In contrast, no cooperation effect on ICAM-1 or E-selectin was observed with a TLR2/TLR1 ligand. Consistent with an increase in adhesion molecule expression, endothelial cell treatment with LPS plus S1P significantly enhanced adhesion of PBMCs under shear stress conditions compared with the effect of either ligand alone and exhibited comparable levels of cell adhesion strength as those after TNF-a treatment. Moreover, LPS and S1P cooperated to increase the expression of proinflammatory molecules such as IL-6, cyclooxygenase-2, and prostacyclin, as determined by ELISA and Western blot. The analysis of signaling pathways revealed the synergistic phosphorylation of ERK upon LPS plus S1P treatment of HUVEC and human aortic endothelial cells and cell-type differences on p38 and NF-kB activation. Moreover, pharmacological and small interfering RNA experiments disclosed the involvement of S1P 1/3 and NF-kB in the cooperation effect and that cell origin determines the S1P receptors and signaling routes involved. Sphingosine kinase activity induction upon LPS plus S1P treatment suggests S1P– Sphingosine kinase axis involvement. In summary, LPS and S1P cooperate to increase proinflammatory molecules in endothelial cells and, in turn, to augment leukocyte adhesion, thus exacerbating S1P-mediated proadhesive/proinflammatory properties. S phingosine-1-phosphate (S1P) is a bioactive lipid mediator that mediates a wide spectrum of cell functions in both intracellular and extracellular compartments, which includes proliferation, migration, differentiation, angiogenesis, and lymphocyte trafficking (1–3). Many of the actions of S1P are mediated by the activation of receptors, initially known as endo-thelial differentiation genes and now designated as S1P 1–5 , which are high-affinity receptors coupled to G proteins (a io , a q , or a 12/13) that trigger the activation of multiple signals leading to specific cell responses (4). In addition, S1P can play an important role as a second messenger during inflammation (2). Accumulating evidence suggests an important role of S1P in the regulation of the immune system and the vascular system (2, 5). The S1P–S1P-receptor signaling axis has been implicated in a variety of pathophysiological conditions and diseases such …

TNF-α-activated eNOS signaling increases leukocyte adhesion through the S-nitrosylation pathway

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the Β2 Integrin Mac-1 and Protein Kinase C Zeda (pkcζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst

S-nitrosocaptopril Interrupts Adhesion of Cancer Cells to Vascular Endothelium by Suppressing Cell Adhesion Molecules Via Inhibition of the NF-кB and JAK/STAT Signal Pathways in Endothelial Cells

Exogenous, but not Endogenous Nitric Oxide Inhibits Adhesion Molecule Expression in Human Endothelial Cells

Effects of Antioxidants and Nitric Oxide on TNF-α-induced Adhesion Molecule Expression and NF-κB Activation in Human Dermal Microvascular Endothelial Cells

Enos S-nitrosylation Mediated OxLDL-induced Endothelial Dysfunction Via Increasing the Interaction of Enos with Β‑catenin.

Src phosphorylation of endothelial cell surface intercellular adhesion molecule-1 mediates neutrophil adhesion and contributes to the mechanism of lung inflammation.

Nuclear eNOS interacts with and S-nitrosates ADAR1 to modulate endothelial gene expression

Nitric oxide inhibits the NLRP3 inflammasome

Cutting Edge: Nitric Oxide Inhibits the NLRP3 Inflammasome.

Nitric Oxide Inhibits the NLRP3 Inflammasome (P1270)

Class I phosphoinositide-3-kinases and SRC kinases play a nonredundant role in regulation of adhesion-independent and -dependent neutrophil reactive oxygen species generation

Endothelial Nitric-Oxide Synthase Enhances Lipopolysaccharide-Stimulated Tumor Necrosis Factor-Alpha Expression Via Camp-Mediated P38 Mapk Pathway in Cardiomyocytes

Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor

Nuclear eNOS interacts with and S-nitrosates ADAR1 to modulate type I interferon signaling and endothelial function.

Protein Kinase C and Protein Tyrosine Kinase Mediate Lipopolysaccharide- and Cytokine-Induced Nitric Oxide Formation in Vascular Smooth Muscle Cells of Rats

Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells

Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes

Leukocyte Adhesion in Endothelial Cells Induce Inflammatory Molecules and Sphingosine-1-Phosphate Cooperate To Lipopolysaccharide

Macrophages Activate Inos Signaling in Adventitial Fibroblasts and Contribute to Adventitia Fibrosis